Related references
Note: Only part of the references are listed.Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice
Jing Pan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Mechanistic Insights of Soluble Uric Acid-related Kidney Disease
Jing Pan et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice
Qian Ren et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Fisetin alleviates sepsis-induced multiple organ dysfunction in mice via inhibiting p38 MAPK/MK2 signaling
Hai-feng Zhang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy
Yingfeng Shi et al.
CELL DEATH & DISEASE (2020)
Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy
Min Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Molecular mechanistic insight into the anti-hyperuricemic effect of Eucommia ulmoides in mice and rats
Cong Fang et al.
PHARMACEUTICAL BIOLOGY (2019)
Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition
Saba Tabasum et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Pterostilbene, a bioactive component of blueberries, alleviates renal fibrosis in a severe mouse model of hyperuricemic nephropathy
Jing Pan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation
Chenxu Ge et al.
FOOD & FUNCTION (2019)
Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study
Fengqin Li et al.
BMC NEPHROLOGY (2018)
Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway
Ying Jing et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
D. J. Junk et al.
ONCOGENE (2017)
被撤回的出版物: High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway (Retracted article. See vol. 52, pg. 604, 2021)
Huifang Liu et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Hyperuricemia-induced inflammasome and kidney diseases
Yoshitaka Isaka et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways
Thamaraiselvan Rengarajan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
Marian Goicoechea et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
The Molecular Physiology of Uric Acid Homeostasis
Asim K. Mandal et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 77 (2015)
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy
Na Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
Rui Liu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Uric Acid as a Target of Therapy in CKD
Diana I. Jalal et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study
Gianluca Trifio et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Fisetin: A Dietary Antioxidant for Health Promotion
Naghma Khan et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Uric acid and chronic kidney disease: which is chasing which?
Richard J. Johnson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite
Yasmine S. Touil et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells
Zhou Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Uric Acid and Long-term Outcomes in CKD
Magdalena Madero et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Share Paper
